Innovations in Cancer Treatment and Predictive Modeling Capture 2018 Wells and Kuzneski Competitions

A year ago the Food and Drug Administration (FDA) approved the first gene therapy in the U.S. The drug, Kymyriah, from pharmaceutical company Novartis, is a type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy. It was approved to treat acute lymphoblastic leukemia, a cancer of the blood.…

Read More

First IBM Bluehack at a University Reveals Pitt Students’ Passion for Problem Solving

October 19, 2018 Over 100 students from across the University, and a few from neighboring Carnegie Mellon, took control of the Pitt School of Computing and Information building on Bellefield Avenue last weekend hacking their ideas for improving healthcare, the Internet of Things (IoT), and any other idea they could…

Read More

University of Pittsburgh Announces Patents Issued in September 2018

October 12, 2018 The University of Pittsburgh announced that Pitt innovators were issued seven patents in September 2018. Featured Patent: U.S. 10,071,172 “Endogenous Neogenesis of Beta Cells” A Pitt innovation team led by George Gittes, director of the Richard King Mellon Foundation Institute for Pediatric Research,  have developed a gene…

Read More

Pitt Innovation Challenge Awards $475,000 to Teams Solving Clinical Problems

  PInCh Awards Show That for Some Pitt Faculty, Entrepreneurship is Infectious October 2, 2018 A breathylizer to detect cancer, a new treatment that addresses the cause, not the symptoms, of chronic obstructive pulmonary disorder (COPD) and a catheter that makes inserting an intravenous line easier each received $100,000 to…

Read More